Koya Medical Honored by Goldman Sachs for Entrepreneurship
Koya Medical CEO Andy Doraiswamy was named one of the Most Exceptional Entrepreneurs of 2025 by Goldman Sachs (NYSE: GS) at the Builders and Innovators Summit on October 15, 2025 in Healdsburg, California.
Goldman Sachs selected Doraiswamy from multiple industries and highlighted Koya Medical's work on a comprehensive vascular care solution across home, office, and surgical settings. Doraiswamy previously led ophthalmology innovations, including intraocular implants acquired by Santen and marketed by Bausch + Lomb as enVista IOL.
Il CEO di Koya Medical, Andy Doraiswamy è stato nominato uno dei Più Eccezionali Imprenditori del 2025 da Goldman Sachs (NYSE: GS) al Summit Builders and Innovators il 15 ottobre 2025 a Healdsburg, California.
Goldman Sachs ha selezionato Doraiswamy tra diverse industrie e ha messo in evidenza il lavoro di Koya Medical su una soluzione completa per la cura vascolare tra casa, ufficio e contesti chirurgici. Doraiswamy ha precedentemente guidato innovazioni nel campo dell'ophtalmologia, inclusi impianti intraoculari acquisiti da Santen e commercializzati da Bausch + Lomb come enVista IOL.
El CEO de Koya Medical, Andy Doraiswamy fue nombrado uno de los Emprendedores Más Excepcionales de 2025 por Goldman Sachs (NYSE: GS) en la Cumbre de Builders e Innovators el 15 de octubre de 2025 en Healdsburg, California.
Goldman Sachs seleccionó a Doraiswamy entre múltiples industrias y destacó el trabajo de Koya Medical en una solución integral de cuidado vascular que abarca el hogar, la oficina y entornos quirúrgicos. Doraiswamy dirigió previamente innovaciones en oftalmología, incluyendo implantes intraoculares adquiridos por Santen y comercializados por Bausch + Lomb como enVista IOL.
Koya Medical의 CEO Andy Doraiswamy가 Goldman Sachs(NYSE: GS)가 선정하는 2025년 가장 뛰어난 기업가 중 한 명으로 꼽혔고, 2025년 10월 15일에 캘리포니아 주 헤일드스버그에서 열린 Builders and Innovators Summit에서 발표되었습니다.
Goldman Sachs는 여러 산업에서 Doraiswamy를 선택했고 가정, 사무실, 수술 환경 전반에 걸친 혈관 관리 솔루션에 대한 Koya Medical의 작업을 강조했습니다. Doraiswamy는 이전에 시력 보존과 관련된 혁신을 이끌었으며, Santen이 인수하고 Bausch + Lomb이 enVista IOL로 판매한 망내 임플란트를 포함합니다.
Le PDG de Koya Medical, Andy Doraiswamy a été nommé l'un des Entrepreneurs les Plus Exceptionnels de 2025 par Goldman Sachs (NYSE: GS) lors du Builders and Innovators Summit le 15 octobre 2025 à Healdsburg, en Californie.
Goldman Sachs a sélectionné Doraiswamy parmi plusieurs industries et a mis en évidence le travail de Koya Medical sur une solution de soins vasculaires complète couvrant le domicile, le bureau et les environnements chirurgicaux. Doraiswamy a précédemment dirigé des innovations en ophtalmologie, y compris des implants intraoculaires acquis par Santen et commercialisés par Bausch + Lomb sous le nom enVista IOL.
Der CEO von Koya Medical, Andy Doraiswamy wurde am 15. Oktober 2025 bei dem Builders and Innovators Summit in Healdsburg, Kalifornien, von Goldman Sachs (NYSE: GS) zu den Außergewöhnlichsten Unternehmern des Jahres 2025 gezählt.
Goldman Sachs wählte Doraiswamy aus verschiedenen Branchen aus und hob Koya Medicals Arbeit an einer umfassenden Lösung für vaskuläre Versorgung hervor, die zu Hause, im Büro und in operativen Einstellungen eingesetzt wird. Doraiswamy leitete zuvor Innovationen in der Ophthalmologie, einschließlich intraokularer Implantate, die von Santen erworben und von Bausch + Lomb als enVista IOL vermarktet wurden.
الرئيس التنفيذي لشركة Koya Medical، آندي دورايسوامي تم اختياره من قبل Goldman Sachs (NYSE: GS) كأحد رواد الأعمال الأكثر استثنائية في 2025 في قمة Builders and Innovators في 15 أكتوبر 2025 في هيلدسبرغ، كاليفورنيا.
اختارت Goldman Sachs دورايسوامي من بين صناعات متعددة وأبرزت عمل Koya Medical على حل رعاية وعائية شامل يغطي البيئات المنزلية والمكاتب والجراحية. قاد دورايسوامي سابقًا ابتكارات في طب العيون، بما في ذلك زراعات داخل العين استحوذت عليها Santen وتُروَّج لها Bausch + Lomb كـ enVista IOL.
Koya Medical 的首席执行官 Andy Doraiswamy被 Goldman Sachs（NYSE: GS）在 2025 年 10 月 15 日于加利福尼亚州希尔德斯堡举行的 Builders and Innovators Summit 上评为 2025 年最杰出的企业家之一。
Goldman Sachs 从多个行业中挑选了 Doraiswamy，并强调 Koya Medical 在家庭、办公室和外科环境中对血管护理的综合解决方案所作的工作。 Doraiswamy 之前领导了眼科创新，包括被 Santen 收购并由 Bausch + Lomb 以 enVista IOL 推广销售的晶体植入物。
- None.
- None.
Koya Medical CEO Andy Doraiswamy Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit
Goldman Sachs selected Koya CEO Andy Doraiswamy from multiple industries to be honored at the two-day event. He enjoys bringing bold, loving, and innovative teams together to enable health and access across our planet. Previously, he led key developments in ophthalmology with innovations including sight-restoring intraocular implants that have given sight to more than 10 million humans across the globe. This technology was acquired by Santen Pharmaceutical Co., Ltd and is currently marketed by Bausch + Lomb (marketed as enVista® IOL). He trained as a scientist with a specialization in biomedical applications to solve diseases and extend healthy human life.
"It is a great honor to be recognized by Goldman Sachs among such a distinguished group of entrepreneurs," said Doraiswamy. "This recognition is a reflection of the Koya Medical team's dedication to pioneering a comprehensive vascular care solution across the home, office, and surgical continuum."
"We are pleased to recognize Andy Doraiswamy as one of the most exceptional entrepreneurs of 2025," said David Solomon, Chairman and CEO of Goldman Sachs. "The Koya Medical team have not only built a successful enterprise, they are redefining industry paradigms. This year's Summit has brought together many of the best business minds to talk about harnessing the full potential of AI and building the next generation of businesses."
In its 14th year, Goldman's Builders and Innovators Summit is the can't miss gathering for Founders and CEOs of hypergrowth companies. Previous honorees have gone on to lead multi-billion dollar companies, both in the private and public markets. In addition to honoring the most exceptional entrepreneurs each year, the Summit consists of general sessions and clinics led by seasoned entrepreneurs, academics and business leaders as well as resident scholars.
About Koya Medical
Founded in 2018 and headquartered in
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—highlighting the urgent need for modern, evidence-based, and scalable solutions.
About Goldman Sachs
Goldman Sachs is a leading global financial institution that delivers a broad range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in
Learn more at www.koyamedical.com and follow Koya on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/koya-medical-honored-by-goldman-sachs-for-entrepreneurship-302583941.html
SOURCE Koya Medical
FAQ
What recognition did Andy Doraiswamy of Koya Medical receive on October 15, 2025?
Which company hosted the Builders and Innovators Summit where Koya Medical CEO was honored?
How does the Goldman Sachs honor relate to Koya Medical's business focus in 2025?
What past ophthalmology innovation is credited to Andy Doraiswamy in the October 15, 2025 announcement?
When was the Goldman Sachs Builders and Innovators Summit held where the award was given?
